Chen Y, Li S, Yin M, Li Y, Chen C, Zhang J, et al
The drug doseresponse with respect to side effects, safety, and efficacy for the treatment of obesity are not much known
These are GLP-1, GIP, and glucagon pathways
Novo Nordisks Marketing Since 2018, Novo Nordisk has engaged in a large-scale marketing campaign touting the weight-loss benefits of Ozempic and Wegovy
Those with a strong appetite-driven eating pattern typically see more pronounced effects than those with metabolic-driven weight gain
This local response is the immune system's normal reaction to a foreign substance entering the skin and usually fades without intervention